Download full-text PDF |
Source |
---|
Heart Rhythm
March 2025
Ospedale Giovanni Paolo II, ASP di Ragusa, Ragusa, Italy.
Background: Medtronic Micra VR and Abbott Aveir VR are two single-chamber ventricular leadless pacemakers (L-PMs) currently available in clinical practice. They differ in their design, fixation mechanism (tine-based fixation for Micra VR, screw-in helix fixation for Aveir VR), and implantation technique. Little comparative safety data are available for these LPMs.
View Article and Find Full Text PDFInt J Antimicrob Agents
February 2025
Department of Public Health and Paediatrics, University of Torino, Turin, Italy; Microbiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, Turin, Italy.
Introduction: Despite being implicated in a wide spectrum of community- and healthcare-acquired infections, anaerobes have not yet been incorporated into systematic surveillance programs in Europe.
Methods: We conducted a multicentre retrospective observational study analysing all anaerobic strains isolated from blood cultures in 44 European Hospital Centres over a 4-year period (2020-2023). Diagnostic approach, epidemiology, and antimicrobial susceptibility according to EUCAST v.
BMC Infect Dis
February 2025
Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou branch, No.5, Fuxing St., Guishan, 33305, Taoyuan, Taiwan.
Background: Purulent pericarditis is a rare, life-threatening condition often caused by Streptococci, Staphylococci, Haemophilus species, or Mycobacterium tuberculosis. Coinfection cases are exceedingly uncommon. We aim to document and share this rare case through this case report.
View Article and Find Full Text PDFPacing Clin Electrophysiol
March 2025
Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers, Milwaukee, Wisconsin, USA.
Background: Concurrent Micra leadless pacemaker (Medtronic, Minneapolis, Minnesota) implantation and atrioventricular node (AVN) ablation has been shown to be feasible and safe in patients with symptomatic, drug-refractory atrial fibrillation (AF). However, major complications within the 30 days after concurrent Micra implantation and AVN ablation have been reported. We evaluated the efficacy and safety of the concurrent procedure at our institution.
View Article and Find Full Text PDFMicromachines (Basel)
January 2025
Section of Electrophysiology, Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, 1653 W. Congress, Chicago, IL 60612, USA.
Although significant strides have been made in cardiac pacing, the field is still evolving. While transvenous permanent pacing is highly effective in the management of bradyarrhythmias, it is not risk free and may result in significant morbidity and, rarely, mortality. Transvenous leads are often the weakest link in a pacing system.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!